Baheyeldin M. Salem, MD
- Cancer and Blood Disorders
Associate Professor, Department of Pediatrics, Section of Hematology/Oncology, Baylor College of Medicine
Office location:
Texas Medical Center
6701 Fannin Street
Houston, TX 77030
Get to know Baheyeldin M. Salem, MD
Dr. Baheyeldin (Bahey) Salem is a dedicated pediatric stem cell transplant (SCT) physician. He provides direct clinical care to a large number of patients with a variety of conditions requiring bone marrow transplantation.
Dr. Salem has trained and worked in some of the nation's largest stem cell transplant programs and has experience treating patients with malignant (e.g., blood cancer or leukemia), as well as non-malignant disease requiring stem cell transplantation. He has special interest in treating patients with leukemia, both with standard transplant approaches, as well as using newer targeted cell therapy protocols.
Dr. Salem believes that understanding the biology of conditions such as leukemia (what makes the disease develop in the first place), would enable us to provide treatments that are "tailored" to each patient. This is achieved by targeting the specific defect or mutation that leads to the development of leukemia or to the resistance of leukemia cells to chemotherapy.
As a stem cell transplant physician, Dr. Salem provides direct care for patients admitted to the inpatient unit who are undergoing transplant for a wide variety of conditions. He also regularly provides clinical care in the outpatient setting before and after transplant.
As a member of the Center for Cell and Gene Therapy (CAGT), Dr. Salem will be involved in conducting clinical trials with a wide variety of clinical applications for certain eligible patients.
Additionally, Dr. Salem has a special interest in the microbiome and how it relates to stem cell transplantation. This area focuses on studying the collective network of microbes living inside and on the surface of the human body and how they affect the outcome of stem cell transplantation.
Education
| School | Education | Degree | Year |
|---|---|---|---|
| University of Minnesota | Fellowship | Pediatric Blood and Marrow Transplantation | 2016 |
| George Washington University | Fellowship | Pediatric Hematology/Oncology | 2015 |
| University of Connecticut | Residency | Pediatrics | 2012 |
| Cairo University Pediatric Teaching Hospitals | Residency | Pediatrics | 2007 |
| University Faculty of Medicine, Egypt | Medical School | Medicine and Surgery | 2004 |
Organizations
| Organization Name | Role |
|---|---|
| American Academy of Pediatrics (AAP) | Member |
| American Medical Association (AMA) | Member |
| American Society of Bone Marrow Transplantation (ASBMT) | Member |
| American Society of Hematology (ASH) | Member |
| American Society of Pediatric Hematology/Oncology (ASPHO) | Member |
| Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL) | Member, Immune Effector Cell Therapy Working Group |
Board Certifications
American Board of Pediatrics
American Board of Pediatrics - Pediatric Hematology/Oncology
* Texas Children’s Hospital physicians’ licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician’s office and were not verified by Texas Children’s Hospital.
Highlights
Bringing Leukemia Research to the Bedside: Texas Children...
Research Area:
Cell and gene therapy
Dr. Salem's research interest is focused on two main areas: studying the microbiome in the setting of stem cell transplantation and how it can be manipulated to improve outcomes after bone marrow transplantation.
His second area of research focus is on minimizing risk of relapse after stem cell transplant by different approaches including optimizing the conditioning regimen and choice of donor, as well as use of cellular therapies and other transplant-enabling therapies when appropriate.
By optimizing the use of cellular therapies in addition to stem cell transplant and by better understanding the role of the microbiome in the stem cell transplantation setting, we can improve the overall outcome after stem cell transplants for patients with malignant, as well as non-malignant diseases.
The ultimate goal of Dr. Salem's research is to develop treatment plans to improve survival of patients after receiving a stem cell transplant, free of any residual or recurrent disease.
Dr. Salem has been involved in research projects aiming at treating one of the most common and serious complications after stem cell transplantation, called graft-versus-host-disease (GVHD), specifically cases that are resistant to corticosteroids.
Dr. Salem has published his research work in some of the major peer-reviewed scientific journals, including Blood Journal and the British Journal of Haematology.